Patents by Inventor David R. Anderson

David R. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190183509
    Abstract: An example medical device for occluding the left atrial appendage is disclosed. The example medical device for occluding the left atrial appendage includes an expandable member having a first end region, a second end region and an inflation cavity. The medical device also includes a plurality of spine members coupled to the expandable member, the plurality of spine members spaced circumferentially around an outer surface of the expandable member. Additionally, the medical device includes a valve member extending at least partially into the inflation cavity, wherein the plurality of spine members are configured to position the medical device within an opening of the left atrial appendage and wherein the expandable member is configured to expand and seal the opening of the left atrial appendage.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: James M. Anderson, John M. Edgell, Jose A. Meregotte, Steven R. Larsen, David Raab, Peter John Hoffman, David John Onushko
  • Patent number: 10311007
    Abstract: This invention is a bus communication protocol. A master device stores bus credits. The master device may transmit a bus transaction only if it holds sufficient number and type of bus credits. Upon transmission, the master device decrements the number of stored bus credits. The bus credits correspond to resources on a slave device for receiving bus transactions. The slave device must receive the bus transaction if accompanied by the proper credits. The slave device services the transaction. The slave device then transmits a credit return. The master device adds the corresponding number and types of credits to the stored amount. The slave device is ready to accept another bus transaction and the master device is re-enabled to initiate the bus transaction. In many types of interactions a bus agent may act as both master and slave depending upon the state of the process.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: June 4, 2019
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: David M. Thompson, Timothy D. Anderson, Joseph R. M. Zbiciak, Abhijeet A. Chachad, Kai Chirca, Matthew D. Pierson
  • Publication number: 20190152912
    Abstract: The present disclosure relates to N-alkylaryl-5-oxyaryl-octadihydrocyclopent[c]pyrrole negative allosteric modulators of NR2B receptors useful in the treatment of neurological diseases having the Formula I: where R1, R2, L1, L2, X, Y, and Y? are described therein.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 23, 2019
    Applicant: CADENT THERAPEUTICS, INC.
    Inventors: David R. ANDERSON, Robert A. VOLKMANN, Frank S. MENNITI
  • Patent number: 10239835
    Abstract: The present invention relates to N-alkylaryl-5-oxyaryl-octadihydrocyclopent[c]pyrrole negative allosteric modulators of NR2B receptors useful in the treatment of neurological diseases having the Formula I where R1, R2, L1, L2, X, Y, and Y? are described therein. In an aspect, compounds of formula I are described and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or stereoisomers thereof wherein: L1 is straight or branched C1-C5 alkyl optionally substituted with one or more substituents selected from the group consisting of OH, ORIO, NH2, NHRio, and N(Rlo)(Rio?) provided that no more than one oxygen or nitrogen is attached to any carbon.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: March 26, 2019
    Assignee: CADENT THERAPEUTICS, INC.
    Inventors: David R. Anderson, Robert A. Volkmann, Frank S. Menniti
  • Publication number: 20180369245
    Abstract: Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 27, 2018
    Applicant: Cadent Therapeutics, Inc.
    Inventors: David R. ANDERSON, Robert A. VOLKMANN, Frank S. MENNITE, Christopher FANGER
  • Publication number: 20180362541
    Abstract: Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated modulate the NMDA receptor.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Inventors: David R. ANDERSON, Robert A. VOLKMANN, Frank S. MENNITE, Christopher FANGER
  • Publication number: 20180360837
    Abstract: Disclosed herein, in part, are methods of treating neurological disorders, e.g., schizophrenia and major depressive disorder, comprising administering an effective amount of a disclosed heterocyclic compound. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 20, 2018
    Inventors: David R. ANDERSON, Robert A. VOLKMANN, Frank S. MENNITE, Christopher FANGER
  • Publication number: 20180325868
    Abstract: Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Applicant: Cadent Therapeutics, Inc.
    Inventors: David R. Anderson, Robert A. Volkmann, Frank S. Menniti
  • Patent number: 10052306
    Abstract: Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: August 21, 2018
    Assignee: CADENT THERAPEUTICS, INC.
    Inventors: David R. Anderson, Robert A. Volkmann, Frank S. Menniti
  • Patent number: 9963434
    Abstract: Compounds of the Formula wherein A, B, C, D, X, Y, Z, R1, R2, R2?, R3 and n are described herein, selectively negatively modulate NMDA receptors containing an NR2A subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: May 8, 2018
    Assignee: Luc Therapeutics, Inc.
    Inventors: David R Anderson, Robert A Volkmann
  • Publication number: 20180111902
    Abstract: The present invention relates to N-alkylaryl-5-oxyaryl-octadihydrocyclopent[c]pyrrole negative allosteric modulators of NR2B receptors useful in the treatment of neurological diseases having the Formula I where R1, R2, L1, L2, X, Y, and Y? are described therein. In an aspect, compounds of formula I are described and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or stereoisomers thereof wherein: L1 is straight or branched C1-C5 alkyl optionally substituted with one or more substituents selected from the group consisting of OH, ORIO, NH2, NHRio, and N(Rlo)(Rio?) provided that no more than one oxygen or nitrogen is attached to any carbon.
    Type: Application
    Filed: September 23, 2015
    Publication date: April 26, 2018
    Applicant: Luc Therapeutics, Inc.
    Inventors: David R. ANDERSON, Robert A. VOLKMANN, Frank S. MENNITI
  • Publication number: 20170286609
    Abstract: A relationship management device and method providing a user interface containing treatment protocol for an individual comprising: (a) a user interface electrically connected with a data storage device; (b) a server electrically connected with the user interface and the data storage device; and (c) a treatment processor electrically connected with the server, wherein the treatment processor is configured to generate an optimized treatment protocol for the individual.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 5, 2017
    Applicant: OPTUMINSIGHT, INC.
    Inventors: David R. Anderson, Jean Rawlings
  • Patent number: 9753994
    Abstract: System and methods for rapid generation of attribute driven temporal clustering are provided. In one embodiment, the system includes a data storage device and a server. The data storage device may be configured to store a database comprising a plurality of records. The system may also include a server in data communication with the data storage device. The server may be suitably programmed to receive a first attribute and a second attribute, search a database stored on a data storage device to obtain a first group of records associated with the first attribute, search the first group of records to obtain a second group of records associated with the second attribute, determine a temporal relationship between a first index date of a first attribute and a second index date of the second attribute, and generate an output comprising a graphical representation of the temporal relationship.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: September 5, 2017
    Assignee: OPTUMINSIGHT, INC.
    Inventor: David R. Anderson
  • Publication number: 20170140406
    Abstract: Systems, methods, and other embodiments are disclosed that are configured to maximize expected net revenue for a retail item. In one embodiment, input data associated with a retail item is read. A total inventory amount for the retail item that is available for distribution is initially allocated across sales channels where the retail item is sold to form a plurality of allocated inventory amounts, as represented in an inventory allocation data structure. An attempt is made to equalize marginal revenue values associated with the retail item across the sales channels as represented in a marginal revenue data structure. The allocated inventory amounts are iteratively adjusted, and marginal revenue values are iteratively updated based on the input data and the adjusted allocated inventory amounts for the sales channels. As the updated marginal revenue values approach equalization across the sales channels, the expected net revenue approaches maximization.
    Type: Application
    Filed: November 16, 2015
    Publication date: May 18, 2017
    Inventors: David R. ANDERSON, John S. BIBLE, Patrick J. BOHANNON
  • Publication number: 20170071906
    Abstract: Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Inventors: David R. Anderson, Robert A. Volkmann, Frank S. Menniti
  • Patent number: 9540324
    Abstract: Compounds that selectively negatively modulate NMDA receptors containing an NR1/NR2B subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: January 10, 2017
    Assignee: LUC THERAPEUTICS, INC.
    Inventors: David R. Anderson, Robert A. Volkmann, Frank S. Menniti
  • Publication number: 20160311782
    Abstract: Compounds that selectively negatively modulate NMDA receptors containing an NR2A subunit, pharmaceutical compositions comprising the compounds, and methods of treating a disease using the compounds are disclosed.
    Type: Application
    Filed: September 26, 2014
    Publication date: October 27, 2016
    Inventors: David R Anderson, Robert A Volkmann
  • Patent number: 9450406
    Abstract: A system for controlling an electricity supply to a load comprises at least one battery for storing energy. The system also comprises a controller for determining when to switch between a first mode wherein electricity is supplied to the load from a mains electricity circuit; and a discharging mode wherein electricity is supplied from the battery to the load via the mains electricity circuit. The determining is based on information associated with the electricity supply.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: September 20, 2016
    Assignee: The Technology Partnership PLC
    Inventors: Mathew R. Palmer, Antony W. Rix, David R. Anderson, David S. Smith, Matthew C. B. Lumb
  • Patent number: 9195732
    Abstract: Efficient SQL based multi-attribute clustering of data attributes may be used to identify the most relevant combination of data attributes to an outcome. A global outcome value may be calculated to represent an average of the outcome. A subset outcome value for each subset of data attributes of a plurality of attributes may be calculated to represent average of the outcome for the subset. For each subset of data attributes, a number of members associated with the subset may be compared to a threshold, and the subsets with less members than the threshold may be removed. The subset outcome value for each subset of data attributes may be compared to the global outcome value, and a report may be generated that identifies each subset for which the corresponding subset outcome value is greater than or less than the global outcome value.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 24, 2015
    Assignee: OPTUM, INC.
    Inventors: David R. Anderson, Christopher A. Hane
  • Patent number: 9129059
    Abstract: Techniques suitable for identifying potential subjects for a clinical trial and other applications are disclosed. One or more exclusion or inclusion criteria are defined for the clinical trial. One or more specialized searching tables are pre-generated using administrative healthcare claims data and the one or more exclusion or inclusion criteria. The specialized searching tables are searched. Through the searching step, subjects are identified within the administrative healthcare claims data who match the one or more exclusion or inclusion criteria. Through the searching step, a geographical area is identified corresponding to the subjects who match the one or more exclusion or inclusion criteria. A customized report is generated using the identified subjects and geographical area.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: September 8, 2015
    Assignee: OPTUMINSIGHT, INC.
    Inventors: Jean W. Rawlings, David R. Anderson, Carl Kraus, Andrew Paris